Graham Sheridan, whose project entitled ‘Promoting neuroprotection and myelin repair: Novel therapeutic strategies to combat Multiple Sclerosis’, has received funding from the Royal Society.

Graham writes, “The primary focus of this project is to discover new regenerative treatments for Multiple Sclerosis (MS); a neuroinflammatory disorder characterised by demyelinating lesions of the central nervous system (CNS).

“Over 100,000 people in the UK and approximately 2.5 million people worldwide are diagnosed with MS. There is no cure and current anti-inflammatory immunomodulatory drugs only slow disease progression.

“In this project, we will test new drugs that could potentially prevent secondary progressive loss of neurons and promote remyelination of brain and spinal cord lesions.”

Well done to Graham for gaining funding for this important research in to MS.